EDGAR Filing Documents for 0001493152-22-018040

Form DRS - Draft Registration Statement:

SEC Accession No. 0001493152-22-018040

Filing Date

2022-06-29

Accepted

2022-06-29 09:19:52

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.htm	DRS	1448597
2		formdrs_001.jpg	GRAPHIC	3830
3		formdrs_002.jpg	GRAPHIC	45112
4		formdrs_003.jpg	GRAPHIC	47067
5		formdrs_004.jpg	GRAPHIC	78669
6		formdrs_005.jpg	GRAPHIC	92546
7		formdrs_006.jpg	GRAPHIC	176855
	Complete submission text file	0001493152-22-018040.txt		2061747

Mailing Address 324 SOUTH HYDE PARK AVENUE, SUITE 350 TAMPA FL 33606

Business Address 855 N WOLFE STREET #623-6 BALTIMORE MD 21205 813-369-5150

Mira1a Therapeutics, Inc. (Filer) CIK: 0001904286 (see all company filings)

IRS No.: 853354547 | State of Incorp.: FL
Type: DRS | Act: 33 | File No.: 377-06248 | Film No.: 221052239
SIC: 2834 Pharmaceutical Preparations